180 related articles for article (PubMed ID: 2673129)
1. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.
Georgotas A; McCue RE; Cooper TB
Arch Gen Psychiatry; 1989 Sep; 46(9):783-6. PubMed ID: 2673129
[TBL] [Abstract][Full Text] [Related]
2. How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate.
Georgotas A; McCue RE; Cooper TB; Nagachandran N; Chang I
Arch Gen Psychiatry; 1988 Oct; 45(10):929-32. PubMed ID: 3421805
[TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
Georgotas A; McCue RE; Friedman E; Cooper TB
J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
[TBL] [Abstract][Full Text] [Related]
5. Phenelzine for chronic depression: a study of continuation treatment.
Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
[TBL] [Abstract][Full Text] [Related]
6. Relapse of depressed patients after effective continuation therapy.
Georgotas A; McCue RE
J Affect Disord; 1989; 17(2):159-64. PubMed ID: 2527891
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of DST in predicting response to antidepressants: a placebo-controlled study.
Georgotas A; Stokes P; McCue RE; Dubow A; Welkowitz J; Friedman E; Fanelli C; Chang I; Cooper TB
J Affect Disord; 1986; 11(1):21-8. PubMed ID: 2944924
[TBL] [Abstract][Full Text] [Related]
8. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report.
Reynolds CF; Frank E; Perel JM; Imber SD; Cornes C; Morycz RK; Mazumdar S; Miller MD; Pollock BG; Rifai AH
Am J Psychiatry; 1992 Dec; 149(12):1687-92. PubMed ID: 1443245
[TBL] [Abstract][Full Text] [Related]
9. Response of depressive symptoms to nortriptyline, phenelzine and placebo.
Georgotas A; McCue RE; Friedman E; Cooper TB
Br J Psychiatry; 1987 Jul; 151():102-6. PubMed ID: 3676606
[TBL] [Abstract][Full Text] [Related]
10. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
Georgotas A; McCue RE; Friedman E; Cooper T
Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
[TBL] [Abstract][Full Text] [Related]
11. Phenelzine vs placebo in 50 patients with bulimia.
Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
[TBL] [Abstract][Full Text] [Related]
12. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of response to antidepressants in elderly patients.
Georgotas A; McCue RE; Cooper T; Chang I; Mir P; Welkowitz J
Biol Psychiatry; 1987 Jun; 22(6):733-40. PubMed ID: 3297176
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions.
Georgotas A; McCue RE; Friedman E; Cooper TB
Am J Psychiatry; 1987 Jun; 144(6):798-801. PubMed ID: 3592003
[TBL] [Abstract][Full Text] [Related]
15. Response to phenelzine among depressed patients with features of hysteroid dysphoria.
Kayser A; Robinson DS; Nies A; Howard D
Am J Psychiatry; 1985 Apr; 142(4):486-8. PubMed ID: 3883817
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant specificity in atypical depression.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
[TBL] [Abstract][Full Text] [Related]
17. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
[TBL] [Abstract][Full Text] [Related]
18. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
Paykel ES; Rowan PR; Parker RR; Bhat AV
Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission.
Stewart JW; Tricamo E; McGrath PJ; Quitkin FM
Am J Psychiatry; 1997 Jan; 154(1):31-6. PubMed ID: 8988955
[TBL] [Abstract][Full Text] [Related]
20. Use of phenelzine in continuation therapy.
Davidson J; Raft D
Neuropsychobiology; 1984; 11(3):191-4. PubMed ID: 6433222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
